United States Pharmaceuticals

Theravance Biopharma Inc (TBPH)

Track

Track

Theravance Biopharma Inc. experienced notable insider trading activity recently, characterized exclusively by divestments. Executives offloaded shares totaling over $226,000 during the past quarter. These sales occurred following a period where the company missed its latest earnings report expectations. The stock price remains near the midpoint of its annual range despite these consistent liquidation patterns.
Ticker: TBPH Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Theravance Biopharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
321.69
Quantity 13,777 +46.9%
Value US$4,034,246
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
282.86
Quantity 78,584 +36.6%
Value US$904,808
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
421.54
Quantity 92,293 -22.0%
Value US$160,170
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
17.03
Quantity 13,314
Value US$226,793
3.2
Samaha Eli Large shareholder
Transaction date
Sale
Price
17.17
Quantity 5,564 -0.1%
Value US$95,541
3.2
Samaha Eli Large shareholder
Transaction date
Sale
Price
17.04
Quantity 1,400 -0.0%
Value US$23,856
3.2
Samaha Eli Large shareholder
Transaction date
Sale
Price
17.00
Quantity 37,799 -0.4%
Value US$642,628
3.2
Samaha Eli Large shareholder
Transaction date
Sale
Price
17.13
Quantity 25,027 -0.3%
Value US$428,788
3.2
Samaha Eli Large shareholder
Transaction date
Sale
Price
17.23
Quantity 273,871 -2.9%
Value US$4,720,139
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
16.39
Quantity 6,657 -2.8%
Value US$109,079
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
16.38
Quantity 3,328 -1.4%
Value US$54,525
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
16.39
Quantity 3,329 -1.4%
Value US$54,563
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
16.39
Quantity 13,314
Value US$218,167
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
13.92
Quantity 7,766 -3.2%
Value US$108,073
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
14.00
Quantity 15,534 -6.1%
Value US$217,476
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
13.92
Quantity 7,767 -2.9%
Value US$108,088
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
13.96
Quantity 31,067
Value US$433,637
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
18.75
Quantity 15,534 -5.3%
Value US$291,252
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
18.75
Quantity 7,766 -2.6%
Value US$145,619
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
18.75
Quantity 7,767 -2.5%
Value US$145,630
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
18.75
Quantity 31,067
Value US$582,500
1.7
BROSHY ERAN Non-Executive Director
Transaction date
Planned sale
Price
20.00
Quantity 15,501 -25.7%
Value US$310,020
1.7
BROSHY ERAN Non-Executive Director
Transaction date
Planned sale
Price
20.00
Quantity 14,000 -18.9%
Value US$280,000
1.7
ERAN BROSHY Director Non-Executive Director
Transaction date
Proposed sale
Price
20.00
Quantity 29,501
Value US$590,020
1.7
BROSHY ERAN Non-Executive Director
Transaction date
Planned sale
Price
18.50
Quantity 14,000 -23.3%
Value US$259,000
1.7
BROSHY ERAN Non-Executive Director
Transaction date
Planned sale
Price
17.00
Quantity 15,500 -25.1%
Value US$263,500
1.7
BROSHY ERAN Non-Executive Director
Transaction date
Planned sale
Price
18.50
Quantity 29,500 -32.3%
Value US$545,750
1.7
ERAN BROSHY Director Non-Executive Director
Transaction date
Proposed sale
Price
17.98
Quantity 45,000
Value US$809,250
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
11.39
Quantity 4,000 -1.2%
Value US$45,552
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
11.39
Quantity 5,318 -1.6%
Value US$60,548
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
11.39
Quantity 682 -0.2%
Value US$7,770
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
11.39
Quantity 10,000
Value US$113,869
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
11.00
Quantity 24,000 -6.6%
Value US$264,000
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
11.00
Quantity 24,000
Value US$264,000
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
9.00
Quantity 4,000 -1.1%
Value US$36,000
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
9.00
Quantity 4,000 -1.3%
Value US$36,000
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
9.00
Quantity 4,000
Value US$36,000
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
9.00
Quantity 4,000 -1.2%
Value US$36,000
3.2
Samaha Eli Large shareholder
Transaction date
Purchase
Price
7.80
Quantity 999,800 +11.7%
Value US$7,798,440
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
9.00
Quantity 4,000 -1.2%
Value US$36,000
3.2
Samaha Eli Large shareholder
Transaction date
Purchase
Price
8.75
Quantity 499,324 +6.2%
Value US$4,369,085
3.2
Samaha Eli Large shareholder
Transaction date
Purchase
Price
8.75
Quantity 999,800 +14.3%
Value US$8,748,250
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
8.71
Quantity 1,254 -0.4%
Value US$10,922
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
10.29
Quantity 1,378 -0.4%
Value US$14,180
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
10.22
Quantity 2,482 -0.7%
Value US$25,366
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
10.22
Quantity 2,482
Value US$25,366
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
9.03
Quantity 2,482 -0.7%
Value US$22,412
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
9.03
Quantity 2,482
Value US$22,412
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
9.89
Quantity 2,482 -0.7%
Value US$24,547
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
9.89
Quantity 2,482
Value US$24,547
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
9.47
Quantity 1,807 -0.5%
Value US$17,112
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
9.99
Quantity 2,322 -0.7%
Value US$23,197
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
9.99
Quantity 2,322
Value US$23,197
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
9.84
Quantity 2,322 -0.7%
Value US$22,848
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
9.84
Quantity 2,322
Value US$22,848
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
10.69
Quantity 2,322 -0.7%
Value US$24,822
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
10.69
Quantity 2,322
Value US$24,822
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
11.13
Quantity 1,790 -0.5%
Value US$19,923
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
11.13
Quantity 1,790
Value US$19,923
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
11.26
Quantity 2,322 -0.6%
Value US$26,146
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
11.26
Quantity 2,322
Value US$26,146
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
11.88
Quantity 2,323 -0.6%
Value US$27,597
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
11.88
Quantity 2,323
Value US$27,597
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
10.32
Quantity 2,323 -0.6%
Value US$23,973
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
10.20
Quantity 4,000 -1.1%
Value US$40,800
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
10.05
Quantity 2,323 -0.6%
Value US$23,346
3.5
Winningham Rick E CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
11.19
Quantity 50,000 -3.6%
Value US$559,500
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Sale
Price
10.73
Quantity 2,084 -0.7%
Value US$22,361
2.8
Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
11.02
Quantity 65,000 -13.7%
Value US$716,242
2.1
GRAHAM RICHARD A SVP, DEVELOPMENT Officer
Transaction date
Sale
Price
9.71
Quantity 4,906 -1.3%
Value US$47,640
2.1
GRAHAM RICHARD A SVP, DEVELOPMENT Officer
Transaction date
Sale
Price
8.79
Quantity 15,086 -3.9%
Value US$132,606
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
8.93
Quantity 1,081 -0.3%
Value US$9,653
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
10.16
Quantity 2,356 -0.7%
Value US$23,947
2.9
WORBOYS PHILIP D SVP, Research & Transl Science Officer
Transaction date
Sale
Price
20.00
Quantity 8,829 -2.5%
Value US$176,580
2.1
GRAHAM RICHARD A SVP, Development Officer
Transaction date
Sale
Price
19.47
Quantity 7,500 -5.7%
Value US$146,058
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-15 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
13,777 +46.9%
321.69
US$4,034,246 		13,777 +46.9% 321.69 US$4,034,246
2026-09-17 2026-09-15 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
78,584 +36.6%
282.86
US$904,808 		78,584 +36.6% 282.86 US$904,808
2026-09-17 2026-09-15 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
92,293 -22.0%
421.54
US$160,170 		92,293 -22.0% 421.54 US$160,170
2026-09-15 2026-09-15 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
13,314
17.03
US$226,793 		13,314 17.03 US$226,793
2026-07-08 2026-07-07 S Sale
3.2
Samaha Eli
Large shareholder
5,564 -0.1%
17.17
US$95,541 		5,564 -0.1% 17.17 US$95,541
2026-07-08 2026-07-06 S Sale
3.2
Samaha Eli
Large shareholder
1,400 -0.0%
17.04
US$23,856 		1,400 -0.0% 17.04 US$23,856
2026-07-01 2026-07-01 S Sale
3.2
Samaha Eli
Large shareholder
37,799 -0.4%
17.00
US$642,628 		37,799 -0.4% 17.00 US$642,628
2026-07-01 2026-06-30 S Sale
3.2
Samaha Eli
Large shareholder
25,027 -0.3%
17.13
US$428,788 		25,027 -0.3% 17.13 US$428,788
2026-07-01 2026-06-29 S Sale
3.2
Samaha Eli
Large shareholder
273,871 -2.9%
17.23
US$4,720,139 		273,871 -2.9% 17.23 US$4,720,139
2026-06-17 2026-06-15 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
6,657 -2.8%
16.39
US$109,079 		6,657 -2.8% 16.39 US$109,079
2026-06-17 2026-06-15 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
3,328 -1.4%
16.38
US$54,525 		3,328 -1.4% 16.38 US$54,525
2026-06-17 2026-06-15 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
3,329 -1.4%
16.39
US$54,563 		3,329 -1.4% 16.39 US$54,563
2026-06-15 2026-06-15 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
13,314
16.39
US$218,167 		13,314 16.39 US$218,167
2026-03-18 2026-03-16 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
7,766 -3.2%
13.92
US$108,073 		7,766 -3.2% 13.92 US$108,073
2026-03-18 2026-03-16 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
15,534 -6.1%
14.00
US$217,476 		15,534 -6.1% 14.00 US$217,476
2026-03-18 2026-03-16 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
7,767 -2.9%
13.92
US$108,088 		7,767 -2.9% 13.92 US$108,088
2026-03-16 2026-03-16 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
31,067
13.96
US$433,637 		31,067 13.96 US$433,637
2025-12-05 2025-12-03 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
15,534 -5.3%
18.75
US$291,252 		15,534 -5.3% 18.75 US$291,252
2025-12-05 2025-12-03 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
7,766 -2.6%
18.75
US$145,619 		7,766 -2.6% 18.75 US$145,619
2025-12-05 2025-12-03 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
7,767 -2.5%
18.75
US$145,630 		7,767 -2.5% 18.75 US$145,630
2025-12-03 2025-12-03 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
31,067
18.75
US$582,500 		31,067 18.75 US$582,500
2025-12-01 2025-11-26 PlS Planned sale
1.7
BROSHY ERAN
Non-Executive Director
15,501 -25.7%
20.00
US$310,020 		15,501 -25.7% 20.00 US$310,020
2025-12-01 2025-11-26 PlS Planned sale
1.7
BROSHY ERAN
Non-Executive Director
14,000 -18.9%
20.00
US$280,000 		14,000 -18.9% 20.00 US$280,000
2025-11-26 2025-11-26 PrS Proposed sale
1.7
ERAN BROSHY

Director

Non-Executive Director
29,501
20.00
US$590,020 		29,501 20.00 US$590,020
2025-11-13 2025-11-11 PlS Planned sale
1.7
BROSHY ERAN
Non-Executive Director
14,000 -23.3%
18.50
US$259,000 		14,000 -23.3% 18.50 US$259,000
2025-11-13 2025-11-11 PlS Planned sale
1.7
BROSHY ERAN
Non-Executive Director
15,500 -25.1%
17.00
US$263,500 		15,500 -25.1% 17.00 US$263,500
2025-11-13 2025-11-11 PlS Planned sale
1.7
BROSHY ERAN
Non-Executive Director
29,500 -32.3%
18.50
US$545,750 		29,500 -32.3% 18.50 US$545,750
2025-11-12 2025-11-11 PrS Proposed sale
1.7
ERAN BROSHY

Director

Non-Executive Director
45,000
17.98
US$809,250 		45,000 17.98 US$809,250
2025-07-16 2025-07-14 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
4,000 -1.2%
11.39
US$45,552 		4,000 -1.2% 11.39 US$45,552
2025-07-16 2025-07-14 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
5,318 -1.6%
11.39
US$60,548 		5,318 -1.6% 11.39 US$60,548
2025-07-16 2025-07-14 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
682 -0.2%
11.39
US$7,770 		682 -0.2% 11.39 US$7,770
2025-07-14 2025-07-14 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
10,000
11.39
US$113,869 		10,000 11.39 US$113,869
2025-06-04 2025-06-02 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
24,000 -6.6%
11.00
US$264,000 		24,000 -6.6% 11.00 US$264,000
2025-06-02 2025-06-02 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
24,000
11.00
US$264,000 		24,000 11.00 US$264,000
2025-04-23 2025-04-21 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
4,000 -1.1%
9.00
US$36,000 		4,000 -1.1% 9.00 US$36,000
2025-01-23 2025-01-21 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
4,000 -1.3%
9.00
US$36,000 		4,000 -1.3% 9.00 US$36,000
2025-01-21 2025-01-21 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
4,000
9.00
US$36,000 		4,000 9.00 US$36,000
2024-11-13 2024-11-11 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
4,000 -1.2%
9.00
US$36,000 		4,000 -1.2% 9.00 US$36,000
2024-08-09 2024-08-07 B Purchase
3.2
Samaha Eli
Large shareholder
999,800 +11.7%
7.80
US$7,798,440 		999,800 +11.7% 7.80 US$7,798,440
2024-07-12 2024-07-10 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
4,000 -1.2%
9.00
US$36,000 		4,000 -1.2% 9.00 US$36,000
2024-05-03 2024-05-01 B Purchase
3.2
Samaha Eli
Large shareholder
499,324 +6.2%
8.75
US$4,369,085 		499,324 +6.2% 8.75 US$4,369,085
2024-05-03 2024-05-01 B Purchase
3.2
Samaha Eli
Large shareholder
999,800 +14.3%
8.75
US$8,748,250 		999,800 +14.3% 8.75 US$8,748,250
2024-02-22 2024-02-22 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
1,254 -0.4%
8.71
US$10,922 		1,254 -0.4% 8.71 US$10,922
2023-11-22 2023-11-21 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
1,378 -0.4%
10.29
US$14,180 		1,378 -0.4% 10.29 US$14,180
2023-11-16 2023-11-14 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,482 -0.7%
10.22
US$25,366 		2,482 -0.7% 10.22 US$25,366
2023-11-14 2023-11-14 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,482
10.22
US$25,366 		2,482 10.22 US$25,366
2023-10-18 2023-10-16 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,482 -0.7%
9.03
US$22,412 		2,482 -0.7% 9.03 US$22,412
2023-10-16 2023-10-16 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,482
9.03
US$22,412 		2,482 9.03 US$22,412
2023-09-18 2023-09-14 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,482 -0.7%
9.89
US$24,547 		2,482 -0.7% 9.89 US$24,547
2023-09-14 2023-09-14 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,482
9.89
US$24,547 		2,482 9.89 US$24,547
2023-08-24 2023-08-22 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
1,807 -0.5%
9.47
US$17,112 		1,807 -0.5% 9.47 US$17,112
2023-08-15 2023-08-11 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,322 -0.7%
9.99
US$23,197 		2,322 -0.7% 9.99 US$23,197
2023-08-11 2023-08-11 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,322
9.99
US$23,197 		2,322 9.99 US$23,197
2023-07-18 2023-07-14 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,322 -0.7%
9.84
US$22,848 		2,322 -0.7% 9.84 US$22,848
2023-07-14 2023-07-14 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,322
9.84
US$22,848 		2,322 9.84 US$22,848
2023-06-16 2023-06-14 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,322 -0.7%
10.69
US$24,822 		2,322 -0.7% 10.69 US$24,822
2023-06-14 2023-06-14 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,322
10.69
US$24,822 		2,322 10.69 US$24,822
2023-06-12 2023-06-08 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
1,790 -0.5%
11.13
US$19,923 		1,790 -0.5% 11.13 US$19,923
2023-06-08 2023-06-08 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
1,790
11.13
US$19,923 		1,790 11.13 US$19,923
2023-05-17 2023-05-15 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,322 -0.6%
11.26
US$26,146 		2,322 -0.6% 11.26 US$26,146
2023-05-15 2023-05-15 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,322
11.26
US$26,146 		2,322 11.26 US$26,146
2023-04-18 2023-04-14 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,323 -0.6%
11.88
US$27,597 		2,323 -0.6% 11.88 US$27,597
2023-04-14 2023-04-14 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,323
11.88
US$27,597 		2,323 11.88 US$27,597
2023-03-16 2023-03-14 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,323 -0.6%
10.32
US$23,973 		2,323 -0.6% 10.32 US$23,973
2023-03-13 2023-03-09 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
4,000 -1.1%
10.20
US$40,800 		4,000 -1.1% 10.20 US$40,800
2023-03-08 2023-03-06 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,323 -0.6%
10.05
US$23,346 		2,323 -0.6% 10.05 US$23,346
2022-12-16 2022-12-14 S Sale
3.5
Winningham Rick E

CHIEF EXECUTIVE OFFICER

Executive Director
50,000 -3.6%
11.19
US$559,500 		50,000 -3.6% 11.19 US$559,500
2022-12-05 2022-12-01 S Sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,084 -0.7%
10.73
US$22,361 		2,084 -0.7% 10.73 US$22,361
2022-11-22 2022-11-18 S Sale
2.8
Hindman Andrew A.

SVP, CHIEF FINANCIAL OFFICER

Officer
65,000 -13.7%
11.02
US$716,242 		65,000 -13.7% 11.02 US$716,242
2022-08-18 2022-08-16 S Sale
2.1
GRAHAM RICHARD A

SVP, DEVELOPMENT

Officer
4,906 -1.3%
9.71
US$47,640 		4,906 -1.3% 9.71 US$47,640
2022-08-11 2022-08-09 S Sale
2.1
GRAHAM RICHARD A

SVP, DEVELOPMENT

Officer
15,086 -3.9%
8.79
US$132,606 		15,086 -3.9% 8.79 US$132,606
2022-05-24 2022-05-23 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
1,081 -0.3%
8.93
US$9,653 		1,081 -0.3% 8.93 US$9,653
2022-03-02 2022-02-28 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
2,356 -0.7%
10.16
US$23,947 		2,356 -0.7% 10.16 US$23,947
2021-03-11 2021-03-09 S Sale
2.9
WORBOYS PHILIP D

SVP, Research & Transl Science

Officer
8,829 -2.5%
20.00
US$176,580 		8,829 -2.5% 20.00 US$176,580
2020-12-16 2020-12-14 S Sale
2.1
GRAHAM RICHARD A

SVP, Development

Officer
7,500 -5.7%
19.47
US$146,058 		7,500 -5.7% 19.47 US$146,058
Explore more

More insider trading research around Theravance Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America